2017 American Transplant Congress
Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.
Background: Chronic opioid use for pain and opioid substitution therapy (OST) are common among patients with cirrhosis. Little is known of transplant center policies and…2017 American Transplant Congress
Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers.
PurposeLow case volume has been associated with lower survival after pediatric lung transplantation. In addition, pediatric lung retransplantation has been associated with low overall survival…2017 American Transplant Congress
A New Strategy for Loco-Regional Therapy of Hepatocellular Carcinoma: Stereotactic Body Radiotherapy as a Bridge to Liver Transplantation.
Background: Transarterial chemoembolization (TACE) or radiofrequency ablation are often used as local Hepatocellular Carcinoma (HCC) treatment while waiting for a liver transplant (LTx). However, it…2017 American Transplant Congress
Association Between Transportation Strategies and Kidney Transplant Center Staff Perceived Racial Disparities.
Department of Surgery, Emory University, Atlanta, GA
Background: Racial disparities exist in access to the transplant evaluation process. One contributing factor for this disparity is travel barriers. Transplant center policies to assist…2017 American Transplant Congress
Transplantation of Organs from Donors with Hepatitis C: The Potential to Substantially Increase Transplant Activity.
Introduction. Organs from hepatitis C virus positive (HCV+ve) donors are commonly declined for transplantation because of the risk of disease transmission, but new direct acting…2017 American Transplant Congress
Kidney Allograft Offers: Predictors of Turndown and the Relationship of Organ Acceptance Sequence to Kidney Allograft Survival.
Background: There is growing interest in understanding patterns of organ acceptance and reducing organ discard. Little is known about how donor factors, holidays, and location…2017 American Transplant Congress
Waitlist Outcomes of Patients Re-Listed Following Failed Donation After Cardiac Death (DCD) Liver Transplant.
Transplant, Mayo Clinic Florida, Jacksonville, FL
Introduction: The outcome for patients re-listed after developing ischemic cholangiopathy(IC) or graft failure following liver transplant(LT) from a DCD donor, remains a significant concern. Better…2017 American Transplant Congress
Treating Hepatitis C+ Patients Before or After Kidney Transplantation: A Medical Decision Analysis.
Some have recommended that HCV+ kidney wait list patients delay HCV treatment with direct acting antiviral agents (DAAs) with the option of receiving an HCV+/HCV-…2017 American Transplant Congress
A Multistate Modeling Analysis of Time-Varying CPRA States and Its Impact on Kidney Transplant: A Focus on KAS Implementation.
Background: Highly sensitized kidney transplant candidates are at higher risk of death on the waiting list(WL). OPTN policy change 8(Kidney Allocation System(KAS)) aimed to improve…2017 American Transplant Congress
Regional Variation in Liver Donor Utilization Across the U.S.
Unequal patient access to deceased donor liver transplantation across the U.S. has generated efforts to redesign the allocation system. Geographic disparities include the severity of…
- « Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 44
- Next Page »